{"id":"W4389409583","doi":"10.1212/wnl.84.14_supplement.p7.248","title":"Switching to Alemtuzumab From Subcutaneous Interferon Beta-1a After CARE-MS II Further Improved MRI Outcomes in Patients With Relapsing-Remitting Multiple Sclerosis (P7.248)","year":2015,"lang":"en","type":"article","venue":"Neurology","topic":"Mycobacterium research and diagnosis","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"NeuroRx Research (Canada); Montreal Neurological Institute and Hospital","funders":"","keywords":"Alemtuzumab; Multiple sclerosis; Relapsing remitting; Medicine; Interferon beta; Interferon beta-1a; Dimethyl fumarate; Glatiramer acetate; Internal medicine; Psychiatry","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005948069,0.0003533363,0.0007560638,0.0002011123,0.000329352,0.0003816623,0.0002614185,0.0003527904,0.001499464],"category_scores_gemma":[0.0009517609,0.0001195868,0.0004725106,0.000241079,0.0002678082,0.0002783439,0.0001652889,0.0005820639,0.0002577569],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004913742,"about_ca_system_score_gemma":0.000511946,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001112288,"about_ca_topic_score_gemma":0.002544925,"domain_scores_codex":[0.9997146,0.00007333182,0.00002660062,0.00008195679,0.00003833494,0.00006518431],"domain_scores_gemma":[0.999613,0.00005153846,0.0001275037,0.00003057472,0.0000435745,0.0001338526],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.201793,0.02261694,0.3726449,0.0007797812,0.001612982,0.001657074,0.0005535006,0.001337012,0.07005849,0.0002337487,0.006443231,0.3202693],"study_design_scores_gemma":[0.03743846,0.2147746,0.7269848,0.0001882862,0.001096022,0.002543934,0.0001972199,0.001336573,0.01039578,0.0002297525,0.00476715,0.00004735431],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9983897,0.0004669915,0.00004483957,0.00004733947,0.00001748465,0.00008225289,0.00008751566,0.00001342744,0.0008504589],"genre_scores_gemma":[0.9985404,0.0001599137,0.0001943832,0.0002080033,0.00004483534,0.00006839586,0.0004639204,0.000002201594,0.0003179934],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001499464,"threshold_uncertainty_score":0.005016267,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01827133449162479,"score_gpt":0.2395152572848393,"score_spread":0.2212439227932145,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}